Address
Email address
https://sydameapteek.eeKõik ravimid Südameapteegi e-apteegistSüdameapteegi e-apteek: telli mugavalt ravimid, toidulisandid, vitamiinid ja apteegikosmeetika pakiautomaati, apteeki või koju. Tarne alates 0 eurot.
Name
Veerenni Apteek OÜ
Registry code
14767320
VAT number
EE102183414
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.07.2019 (5)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
9 379 643 €
42 381 €
0%
-
320 277 €
22
Submitted
No tax arrears
13%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ene Bötker 23.02.1962 (62) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2020 30.06.2021 | 2021 30.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 6 030 949 € | 6 331 187 € | 8 753 026 € | 9 379 643 € |
| Net profit (loss) for the period | 5 686 € | 112 843 € | 159 367 € | 42 381 € |
| Profit Margin | 0% | 2% | 2% | 0% |
| Current Assets | 937 058 € | 1 200 607 € | 2 029 987 € | 2 131 191 € |
| Fixed Assets | 200 000 € | 200 000 € | 201 134 € | 208 542 € |
| Total Assets | 1 137 058 € | 1 400 607 € | 2 231 121 € | 2 339 733 € |
| Current Liabilities | 1 131 372 € | 1 282 078 € | 1 953 225 € | 2 019 456 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 5 686 € | 118 529 € | 277 896 € | 320 277 € |
| Employees | 23 | 22 | 23 | 22 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 2 911 306.5 € | 78 602.42 € | 86 761.32 € | 24 |
| 2023 Q4 | 2 914 593.99 € | 85 707.77 € | 72 040.47 € | 26 |
| 2023 Q3 | 2 411 623.42 € | 90 792 € | 82 888.96 € | 25 |
| 2023 Q2 | 2 871 376.59 € | 82 124.72 € | 65 769.66 € | 26 |
| 2023 Q1 | 2 494 756.82 € | 86 684.7 € | 79 888.21 € | 25 |
| 2022 Q4 | 2 821 090.04 € | 95 199.07 € | 68 896.62 € | 26 |
| 2022 Q3 | 2 180 213.6 € | 84 165.61 € | 78 113.33 € | 26 |
| 2022 Q2 | 2 391 076.52 € | 103 858.97 € | 80 092.45 € | 26 |
| 2022 Q1 | 2 105 453.46 € | 105 133.66 € | 85 751.2 € | 29 |
| 2021 Q4 | 2 012 794.67 € | 107 740 € | 72 009.31 € | 31 |
| 2021 Q3 | 1 683 048.96 € | 92 819.44 € | 71 484.74 € | 28 |
| 2021 Q2 | 1 952 665.26 € | 93 091.1 € | 64 234.48 € | 28 |
| 2021 Q1 | 1 679 825.27 € | 102 921.2 € | 71 599.71 € | 27 |
| 2020 Q4 | 1 741 964.6 € | 70 496.42 € | 63 884.7 € | 28 |
| 2020 Q3 | 1 435 103.39 € | 63 643.71 € | 63 798.81 € | 26 |
| 2020 Q2 | 1 635 086.71 € | 71 192.3 € | 62 479.68 € | 28 |
| 2020 Q1 | 672 790.63 € | 59 789.07 € | 47 055.33 € | 28 |
